Advantage Alpha Capital Partners’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-58,505
Closed -$262K – 162
2024
Q3
$262K Sell
58,505
-363,941
-86% -$1.71M 0.06% 163
2024
Q2
$2.31M Sell
422,446
-81,437
-16% -$513K 0.5% 74
2024
Q1
$4.07M Buy
503,883
+204,703
+68% +$1.81M 0.76% 55
2023
Q4
$2.97M Buy
299,180
+7,249
+2% +$56.9K 0.56% 74
2023
Q3
$2.33M Buy
291,931
+81,599
+39% +$820K 0.49% 83
2023
Q2
$2.31M Buy
+210,332
New +$2.17M 0.46% 82

Other funds holding DH

Advantage Alpha Capital Partners's DH Position: Q4 2024 in Review

Advantage Alpha Capital Partners sold out of Definitive Healthcare (DH) in Q4 2024, closing a stake of 58,505 shares — an estimated $262K sold.

Advantage Alpha Capital Partners first reported a position in DH in Q2 2023 and held it in 6 quarters. The position peaked at $4.07M in Q1 2024. 128 funds tracked by Wall St. Rank hold DH as of Q4 2024.

  • Advantage Alpha Capital Partners reported no remaining Definitive Healthcare position as of Q4 2024 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 58,505 Definitive Healthcare shares in Q4 2024, an estimated $262K.
  • Advantage Alpha Capital Partners first reported a position in Definitive Healthcare in Q2 2023 and held it in 6 quarters.
  • Advantage Alpha Capital Partners's Definitive Healthcare position peaked at $4.07M in Q1 2024.
  • 128 funds tracked by Wall St. Rank held Definitive Healthcare as of Q4 2024.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.